Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Mapping/Ablation

Feature Story
The 3rd International Symposium on Left Atrial Appendage (ISLAA 2015): Exploring the New Frontiers in AF, Stroke and More
03/31/2015
The 3rd International Symposium on Left Atrial Appendage (ISLAA) 2015 was held February 6-7, 2015 at the Marina del Rey Marriott in Los Angeles, California.
The 3rd International Symposium on Left Atrial Appendage (ISLAA) 2015 was held February 6-7, 2015 at the Marina del Rey Marriott in Los Angeles, California.
The 3rd International Symposium...
03/31/2015
EP Lab Digest
Cover Story
The Future of Cardiovascular Medicine: TED-Style Talks and Tweets at #ACC15
03/31/2015
As the world—and healthcare providers—become more digitally connected, the ways in which we learn and share ideas is changing.
As the world—and healthcare providers—become more digitally connected, the ways in which we learn and share ideas is changing.
As the world—and healthcare...
03/31/2015
EP Lab Digest
Cover Story
Tenth Annual Medical Mission Trip to Nicaragua: A Bidirectionally Rewarding Voyage
03/31/2015
Christian Machado, MD, and colleagues recently completed their tenth consecutive medical mission trip to Nicaragua, where cardiovascular disease is the number one cause of death. 
Christian Machado, MD, and colleagues recently completed their tenth consecutive medical mission trip to Nicaragua, where cardiovascular disease is the number one cause of death. 
Christian Machado, MD, and...
03/31/2015
EP Lab Digest
Letter from the Editor
Tragus Nerve Stimulation to Prevent AF
03/31/2015
If transcutaneous low-level tragus electrical stimulation does have electrophysiological effects to promote sinus rhythm, it is not clear if it can have a clinically meaningful impact in the maintenance of sinus rhythm in patients with AF.
If transcutaneous low-level tragus electrical stimulation does have electrophysiological effects to promote sinus rhythm, it is not clear if it can have a clinically meaningful impact in the maintenance of sinus rhythm in patients with AF.
If transcutaneous low-level...
03/31/2015
EP Lab Digest
Feature Interview
Emerging Technologies: The Geneva Healthcare Suite
03/13/2015
EPLD speaks with Dr Gilanthony Ungab, Chief Medical Officer of Geneva Healthcare, Inc., about their innovative technology platform for managing data from cardiac devices.
EPLD speaks with Dr Gilanthony Ungab, Chief Medical Officer of Geneva Healthcare, Inc., about their innovative technology platform for managing data from cardiac devices.
EPLD speaks with Dr Gilanthony...
03/13/2015
EP Lab Digest
Feature Interview
Innovations in EP: Interview With Greg Cash
03/03/2015
EPLD speaks with Greg Cash about the proprietary PURE EP™ technology platform, designed to improve the clinical outcomes of electrophysiology procedures. Greg Cash is the President and CEO of BioSig Technologies.
EPLD speaks with Greg Cash about the proprietary PURE EP™ technology platform, designed to improve the clinical outcomes of electrophysiology procedures. Greg Cash is the President and CEO of BioSig Technologies.
EPLD speaks with Greg Cash about...
03/03/2015
EP Lab Digest
Inside the EP Lab
Using a New, Smaller Implantable Loop Recorder to Aid in Arrhythmia Detection and Anticoagulation Decisions After AF Ablation: One User’s Experience
03/03/2015
Dr Latacha discusses how use of an ICM provides the electrophysiologist with a minimally invasive and convenient method for detecting both symptomatic and asymptomatic recurrence after an AF ablation.
Dr Latacha discusses how use of an ICM provides the electrophysiologist with a minimally invasive and convenient method for detecting both symptomatic and asymptomatic recurrence after an AF ablation.
Dr Latacha discusses how use of...
03/03/2015
EP Lab Digest
Cover Story
Patient-Focused Radiation Safety Program in the Electrophysiology Lab
03/03/2015
As technology advances and volume of specialized treatments using ionizing radiation grows in the cath and EP labs, hospitals must ensure that a robust radiation safety program is in place to protect patients and staff.
As technology advances and volume of specialized treatments using ionizing radiation grows in the cath and EP labs, hospitals must ensure that a robust radiation safety program is in place to protect patients and staff.
As technology advances and...
03/03/2015
EP Lab Digest
Cover Story
Persistent Left Atrial Appendage Thrombus With Use of Rivaroxaban
03/03/2015
Brian Marino, DO, and colleagues present 3 patients with persistent LAA thrombus while taking rivaroxaban for at least 4 weeks. 
Brian Marino, DO, and colleagues present 3 patients with persistent LAA thrombus while taking rivaroxaban for at least 4 weeks. 
Brian Marino, DO, and colleagues...
03/03/2015
EP Lab Digest
Letter from the Editor
48 Hours.
03/03/2015
it is common practice to perform, or recommend the performance of, electrical cardioversion without anticoagulation, or a TEE, when AF has been present for less than 48 hours. Where does the 48-hour cutoff come from?
it is common practice to perform, or recommend the performance of, electrical cardioversion without anticoagulation, or a TEE, when AF has been present for less than 48 hours. Where does the 48-hour cutoff come from?
it is common practice to...
03/03/2015
EP Lab Digest

Advertisement

EPLD November 2024 cover

Current Issue

November 2024
Volume 24
Issue 11
Current Issue
Issue Archive

Advertisement

Advertisement

Stay in the know.

EP Lab Digest Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement